Cemiplimab is a monoclonal IgG4 antibody with high affinity that targets programmed death receptor-1 (PD-1) and blocks its interaction with programmed death ligands PD-L1 and PD-L2.
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: ICA10050-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review